Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for Cholangiocarcinoma patients

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue SUPPL.1, 2012, Pages 107-114

  Janan, Montira ^a   Proungvitaya, Siriporn ^a,b   Limpaiboon, Temduang ^a,b   Proungvitaya, Tanakorn ^a   Roytrakul, Sittiruk ^c   Wongkham, Chaisiri ^d   Jearanaikoon, Patcharee ^a,b   Chur In, Siri ^a   Wongkham, Sopit ^d  

^a Centre Research and Development Medical Diagnostic   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^d NONE

Author keywords

Adhesion molecule 1 (ICAM 1); Cholangiocarcinoma; Secretome

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; TUMOR MARKER;

BILE DUCT CARCINOMA; BILE DUCT TUMOR; HUMAN; INTRAHEPATIC BILE DUCT; METABOLISM; TANDEM MASS SPECTROMETRY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOMARKERS, TUMOR; CHOLANGIOCARCINOMA; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; TANDEM MASS SPECTROMETRY;

EID: 84874079847     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.KKSuppl.107     Document Type: Article

References (37)

1. Aljiffry M, Abdulelah A, Walsh M, et al (2009). Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg, 208, 134-47.
2. Bendtsen JD, Jensen LJ, Blom N, et al (2004). Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel, 17, 349-56.
3. Blechacz B, Gores GJ (2008). Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology, 48, 308-21.
4. Fiore E, Fusco C, Romero P, et al (2002). Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cellmediated cytotoxicity. Oncogene, 21, 5213-23.
5. Gho YS, Kim PN, Li HC, et al (2001). Stimulation of tumor growth by human soluble intercellular adhesion molecule-1. Cancer Res, 61, 4253-7.
6. Gho YS, Kleinman HK, Sosne G (1999). Angiogenic activity of human soluble intercellular adhesion molecule-1. Cancer Res, 59, 5128-32.
7. Gogali A, Charalabopoulos K, Zampira I, et al (2010). Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers. Chest, 138, 1173-9.
8. Gu X, Ma C, Yuan D, et al (2011). Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review. Translational Lung Cancer Research, 10, 2218-6751.
9. Khan SA, Thomas HC, Davidson BR, et al (2005). Cholangiocarcinoma. Lancet, 366, 1303-14.
10. Khan SA, Toledano MB, Taylor-Robinson SD (2008). Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford), 10, 77-82.
11. Khuhaprema T, Srivatanakul P (2007). Liver and bile duct. Cancers in Thailand,1998-2000 Bangkok Medical Publisher Bangkok.
12. Kovacs E (2005). The serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble gp130 (sgp130) in different tumour stages. Correlation between the two parameters in progression of malignancy. Biomed Pharmacother, 59, 498-500.
13. Lowry OH, Rosebrough NJ, Farr AL, et al (1951). Protein measurement with the folin phenol reagent. J Biol Chem, 193, 265-75.
14. Malhi H, Gores GJ (2006). Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol, 45, 856-67.
15. Mantur M, Snarska J, Koper O, et al (2009). Serum sICAM, sVCAM and sE-selectin levels in colorectal cancer patients. Folia Histochem Cytobiol, 47, 621-5.
16. Maruo Y, Gochi A, Kaihara A, et al (2002). ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int J Cancer, 100, 486-90.
17. Maruyama M, Kobayashi N, Westerman KA, et al (2004). Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT. Transplantation, 77, 446-51.
18. Mbeunkui F, Fodstad O, Pannell LK (2006). Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS. J Proteome Res, 5, 899-906.
19. Mi H, Dong Q, Muruganujan A, et al (2010). PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the gene ontology consortium. Nucleic Acids Res, 38, 204-10.
20. Mosconi S, Beretta GD, Labianca R, et al (2009). Cholangiocarcinoma. Crit Rev Oncol Hematol, 69, 259-70.
21. Nakata B, Hori T, Sunami T, et al (2000). Clinical significance of serum soluble intercellular adhesion molecule 1 in gastric cancer. Clin Cancer Res, 6, 1175-9.
22. O'Hanlon DM, Fitzsimons H, Lynch J, et al (2002). Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer, 38, 2252-7.
23. Okegawa T, Pong RC, Li Y, et al (2004). The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim Pol, 51, 445-57.
24. Pace G, Di Massimo C, De Amicis D, et al (2011). Inflammation and endothelial activation in benign prostatic hyperplasia and prostate cancer. Int Braz J Urol, 37, 617-22.
25. Park JS, Kim KM, Kim MH, et al (2009). Resveratrol inhibits tumor cell adhesion to endothelial cells by blocking ICAM-1 expression. Anticancer Res, 29, 355-62.
26. Patel T (2001). Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology, 33, 1353-7.
27. Petersen TN, Brunak S, von Heijne G, et al (2011). SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods, 8, 785-6.
28. Reilly PL, Woska JR, Jeanfavre DD, et al (1995). The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1. J Immunol, 155, 529-32.
29. Sripa B, Bethony JM, Sithithaworn P, et al (2010). Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop, 120, 158-68.
30. Sripa B, Leungwattanawanit S, Nitta T, et al (2005). Establishment and characterization of an opisthorchiasisassociated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol, 11, 3392-7.
31. Sripa B, Pairojkul C (2008). Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol, 24, 349-56.
32. St-Pierre Y (2005). Organizing a tete-a-tete between cell adhesion molecules and extracellular proteases: a risky business that could lead to the survival of tumor cells. Front Biosci, 10, 1040-9.
33. Vainer B, Horn T, Nielsen OH (2006). Colonic epithelial cell expression of ICAM-1 relates to loss of surface continuity: a comparative study of inflammatory bowel disease and colonic neoplasms. Scand J Gastroenterol, 41, 318-25.
34. Wang J, Springer TA (1998). Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses. Immunol Rev, 163, 197-215.
35. Wu CC, Hsu CW, Chen CD, et al (2010). Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol Cell Proteomics, 9, 1100-17.
36. Wu HY, Chang YH, Chang YC, et al (2009). Proteomics analysis of nasopharyngeal carcinoma cell secretome using a hollow fiber culture system and mass spectrometry. J Proteome Res, 8, 380-9.
37. Yang L, Froio RM, Sciuto TE, et al (2005). ICAM-1 regulates neutrophil adhesion and transcellular migration of TNFalpha- activated vascular endothelium under flow. Blood, 106, 584-92.